Compare CGEN & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | SRI |
|---|---|---|
| Founded | 1993 | 1965 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.2M | 161.7M |
| IPO Year | 2001 | 1997 |
| Metric | CGEN | SRI |
|---|---|---|
| Price | $2.78 | $6.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 485.8K | 202.8K |
| Earning Date | 05-18-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $824,444,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.09 | $4.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.46 |
| 52 Week Low | $1.23 | $3.78 |
| 52 Week High | $3.24 | $9.71 |
| Indicator | CGEN | SRI |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 50.48 |
| Support Level | $1.45 | $6.24 |
| Resistance Level | N/A | $6.35 |
| Average True Range (ATR) | 0.18 | 0.38 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 53.93 | 54.13 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.